Pedro Rodriguez Cutillas
Fondateur chez Kinomica Ltd.
Profil
Pedro Rodriguez Cutillas is the founder of Activiomics Ltd.
(founded in 2009) and Kinomica Ltd.
(founded in 2016, where he is currently a Director).
He held the position of Director at Activiomics Ltd.
and was previously an active Director at Kinomica Ltd.
Dr. Cutillas also held former positions as Director at Pronostics Ltd., Head-Proteomics at The Medical Research Council, and Head-Analytical Signalling at Barts Cancer Institute.
Dr. Cutillas received his undergraduate and doctorate degrees from University College London.
Postes actifs de Pedro Rodriguez Cutillas
| Sociétés | Poste | Début |
|---|---|---|
Kinomica Ltd.
 Kinomica Ltd. BiotechnologyHealth Technology Kinomica Ltd. develops anti-cancer drug therapies. The company is based in Macclesfield, UK. The British company was founded in 2016 by David Britton, Pedro Rodriguez Cutillas. The CEO is Jane Theaker. | Fondateur | 01/10/2016 |
Anciens postes connus de Pedro Rodriguez Cutillas
| Sociétés | Poste | Fin |
|---|---|---|
Pronostics Ltd.
 Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Barts Cancer Institute
 Barts Cancer Institute Miscellaneous Commercial ServicesCommercial Services Part of St Bartholomew's Hospital Medical College, Barts Cancer Institute operates as a cancer research center. The company is based in London, UK. | Corporate Officer/Principal | - |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - |
Activiomics Ltd.
 Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Fondateur | - |
Formation de Pedro Rodriguez Cutillas
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
Pronostics Ltd.
Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Commercial Services |
Barts Cancer Institute
Barts Cancer Institute Miscellaneous Commercial ServicesCommercial Services Part of St Bartholomew's Hospital Medical College, Barts Cancer Institute operates as a cancer research center. The company is based in London, UK. | Commercial Services |
Kinomica Ltd.
Kinomica Ltd. BiotechnologyHealth Technology Kinomica Ltd. develops anti-cancer drug therapies. The company is based in Macclesfield, UK. The British company was founded in 2016 by David Britton, Pedro Rodriguez Cutillas. The CEO is Jane Theaker. | Health Technology |
